Medication Review with Follow-up Service provided by the Community Pharmacy as a care practice for the optimization of pharmacotherapy in patient with urticaria and pruritus

• Published in: Farmacéuticos comunitarios 2023-10, Vol.15 (4), p.45
• Main Authors: Pérez Rodríguez, Rafael Omar, Barreto Corujo, Nicolás Jesús
• Format: Article
• Language: Spanish
• ISSN: 2173-9218; 2173-9218
• DOI: 10.33620/FC.2173-9218.(2023).24

A 66-year-old woman, ex-smoker, diagnosed with hypertension, hypercholesterolemia, asthma, anxiety and migraine, who presented pruritus and urticaria, was given Medication Review with Follow-Up Service (MRF). She was taking 5 medications.After the review of the pharmacotherapy and conducting an in-depth interview, the presence of pruritus and urticaria was determined as a Negative Outcomes Releated to Medicines (NOM) and a Drug Related Problem (DRP) derived from the use of Rosuvastatin/Ezetimibe, and a possible DRPs of probability of adverse effects and prescription error.It was proposed to the patient to suspend the treatment and a referral was made to the Primary Care Physician (PCP) by means of a referral report that was submitted by the patient at the medical appointment to assess a pharmacological alternative to treat hypercholesterolemia.The proposal was accepted by the PCP. A follow-up of the case was carried out, which allowed verifying the resolution of the DRPs and NOMs detected, achieving an improvement in the patient's health and favoring adherence to treatment.